Eligible patients had histological confirmed stage II-IVM0 malignancies of head and neck and received conventional radiation in adjuvant or definitive settings. Patients were required to have Karnofsky performance status of more than 70. The patients who had prior irradiation of the head and neck, history of allergy to aloe vera, underlying DM and HIV positive were excluded from this study.